At the news
? NEUTRALIMPACT 3/10 PRESS-RELEASE filed Jun 12, 2026 at 03:00 ET
Evaxion receives the 2026 Prix Galien UK Award for Best digital health solution for its AI-Immunology platform. While this is the second Galien recognition in under a year, it is a non-financial, reputational award that does not change the company's clinical or financial trajectory. The filing contains no revenue, EPS, guidance, or other material financial data.
- Evaxion awarded the 2026 Prix Galien UK Award for Best digital health solution for AI-Immunology.
- This is the second recognition from the Prix Galien Foundation in less than a year (previous award in Dec 2025).
- Evaxion is a clinical-stage TechBio company with no revenue or financial data disclosed in this release.
- The award committee comprised 12 experts who evaluated innovation, clinical application, and utility.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access